เลตตา
LETTA
activeLast updated: 2026-07-29
Product & certifications 1
- FDA 1A34/67(NG)drugคงอยู่
ตัวยาสำคัญ
- LEVETIRACETAM100.00 milligramต่อ 1 milliliter
- ประเภทควบคุม
- ยาอันตราย
- ข้อบ่งใช้
- LETTA is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy. LETTA is indicated as adjunctive therapy - in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents, children and infants from 1 month of age with epilepsy. - in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy. - in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.
- รหัส ATC
- N03AX14 (levetiracetam)
ข้อมูลตามที่ขึ้นทะเบียนกับ อย. — ไม่ใช่คำแนะนำการใช้ยา ปรึกษาเภสัชกรหรือแพทย์ก่อนใช้เสมอ
- Category
- ยาสำเร็จรูป
- Trade name
- —
- Company / Manufacturer
- บริษัทแมคโครฟาร์ จำกัดดำเนินกิจการ
- Juristic registration number
- 0105520000998
- Producer's other permits
- See all permits held by this company →
A matching registration number confirms the registration exists — it does not verify that the physical item you hold is genuine. Always compare the product and manufacturer names on the label.
Last updated: 2026-07-29 · Data aggregated from official government databases: NBTC · FDA · TISI · DBD · Dept. of Tourism · ACFSReport incorrect data